Dökmetaş, M.; Muğlu, H.; Özcan, E.; Bayram Kuvvet, B.; Helvacı, K.; Kalacı, E.; Kahraman, S.; Aykan, M.B.; Çiçin, İ.; Selçukbiricik, F.;
et al. Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis. Medicina 2025, 61, 123.
https://doi.org/10.3390/medicina61010123
AMA Style
Dökmetaş M, Muğlu H, Özcan E, Bayram Kuvvet B, Helvacı K, Kalacı E, Kahraman S, Aykan MB, Çiçin İ, Selçukbiricik F,
et al. Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis. Medicina. 2025; 61(1):123.
https://doi.org/10.3390/medicina61010123
Chicago/Turabian Style
Dökmetaş, Meriç, Harun Muğlu, Erkan Özcan, Buket Bayram Kuvvet, Kaan Helvacı, Ender Kalacı, Seda Kahraman, Musa Barış Aykan, İrfan Çiçin, Fatih Selçukbiricik,
and et al. 2025. "Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis" Medicina 61, no. 1: 123.
https://doi.org/10.3390/medicina61010123
APA Style
Dökmetaş, M., Muğlu, H., Özcan, E., Bayram Kuvvet, B., Helvacı, K., Kalacı, E., Kahraman, S., Aykan, M. B., Çiçin, İ., Selçukbiricik, F., Ölmez, Ö. F., & Bilici, A.
(2025). Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis. Medicina, 61(1), 123.
https://doi.org/10.3390/medicina61010123
